I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bachelot T
205
results:
Search for persons
X
Format
Online (205)
Mediatypes
Articles (Online) (114)
Bookchapter (Online) (2)
OpenAccess-fulltext (89)
Languages
french (17)
english (187)
Sorted by: Relevance
Sorted by: Year
?
1
251P Genomic alterations of breast cancer patients with lep..:
Larrouquere, L.
;
Heudel, P-E.
;
Clement, E.
...
ESMO Open. 9 (2024) - p. 103272 , 2024
Link:
https://doi.org/10.1016/..
?
2
204P Clinical features predictive of never-progressive dise..:
Grinda, T.
;
Carton, M.
;
Morganti, S.
...
ESMO Open. 9 (2024) - p. 103226 , 2024
Link:
https://doi.org/10.1016/..
?
3
7P Trastuzumab deruxtecan (T-DXd) for advanced breast cance..:
Dieras, V.C.
;
André, F.
;
Lusque, A.
...
ESMO Open. 9 (2024) - p. 103016 , 2024
Link:
https://doi.org/10.1016/..
?
4
124P Neoadjuvant durvalumab plus endocrine therapy followin..:
Verret, B.
;
Lacroix-Triki, M.
;
Ladoire, S.
...
ESMO Open. 9 (2024) - p. 103112 , 2024
Link:
https://doi.org/10.1016/..
?
5
179O Combination of olaparib, durvalumab and fulvestrant in..:
Guiu, S.
;
Balmaña, J.
;
Lemercier, P.
...
ESMO Open. 9 (2024) - p. 103201 , 2024
Link:
https://doi.org/10.1016/..
?
6
Incidence and outcome of brain and/or leptomeningeal metast..:
Epaillard, N.
;
Lusque, A.
;
Jacot, W.
...
ESMO Open. 9 (2024) 5 - p. 103447 , 2024
Link:
https://doi.org/10.1016/..
?
7
190P French real-world safety and effectiveness of trastuzu..:
Pierga, J-Y.
;
Asselain, B.
;
Teixeira, L.
...
ESMO Open. 9 (2024) - p. 103212 , 2024
Link:
https://doi.org/10.1016/..
?
8
274P Efficacy of surgical gloves (SG) as compression therap..:
Joureau-Chabert, A.
;
Ouldbey, Y.
;
Toussaint, P.
...
ESMO Open. 9 (2024) - p. 103332 , 2024
Link:
https://doi.org/10.1016/..
?
9
237P Overall survival (OS) estimation using target trial em..:
Antoine, A.
;
Perol, D.
;
Robain, M.
...
ESMO Open. 9 (2024) - p. 103258 , 2024
Link:
https://doi.org/10.1016/..
?
10
189O A phase II study of patritumab deruxtecan (HER3-DXd), ..:
Pistilli, B.
;
Ibrahimi, N.
;
Lacroix-Triki, M.
...
ESMO Open. 8 (2023) 1 - p. 101378 , 2023
Link:
https://doi.org/10.1016/..
?
11
121TiP LESS: Single-arm study to de-escalate adjuvant endoc..:
Deluche, E.
;
Michiels, S.
;
Fric, D.
...
ESMO Open. 8 (2023) 1 - p. 101345 , 2023
Link:
https://doi.org/10.1016/..
?
12
Efficacy of front-line treatment for hormone receptor-posit..:
Frenel, J.-S.
;
Lusque, A.
;
Delaloge, S.
...
British Journal of Cancer. , 2023
Link:
https://doi.org/10.1038/..
?
13
217P Incidence and outcome of brain and/or leptomeningeal m..:
Epaillard, N.
;
Lusque, A.
;
Jacot, W.
...
ESMO Open. 8 (2023) 1 - p. 101406 , 2023
Link:
https://doi.org/10.1016/..
?
14
193MO Development of a deep learning model using a large re..:
Vuduc, L.
;
Jacot, W.
;
Frenel, J-S.
...
ESMO Open. 8 (2023) 1 - p. 101382 , 2023
Link:
https://doi.org/10.1016/..
?
15
214P Delphi consensus on the definition of visceral crisis ..:
Nabeth, R.
;
Barthoulot, M.
;
Mailliez, A.
...
ESMO Open. 8 (2023) 1 - p. 101403 , 2023
Link:
https://doi.org/10.1016/..
1-15